Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal of neurology·2026
Same author

Integrated clinical and postmortem profiling in schizophrenia reveals a cognitive subtype linked to cerebrovascular disease.

Translational psychiatry·2026
Same author

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Nature genetics·2026
Same author

Spatial transcriptomics reveals the molecular signatures of prodromal and advanced α-synucleinopathy.

iScience·2026
Same author

Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling.

Annals of neurology·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Melanie Cw Campbell1, Lyndsy Acheson1, Erik L Mason1

  • 1University of Waterloo, Waterloo, ON, Canada.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

非侵入性视网膜成像检测出与神经退行性疾病 (如阿尔茨海默氏症) 和涉及TDP-43的疾病相关的蛋白质沉积物. 这种方法提供了一个具有成本效益的,无染料的诊断工具,用于早期疾病检测和干预.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 眼科和神经病学 眼科和神经病学
  • 生物标志物发现发现
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 使用偏光的非侵入性视网膜成像可以识别预测大脑病理的蛋白质沉积物.
  • 之前的研究区分了阿尔茨海默病 (AD) 中的视网膜沉积与与α-synuclein相关的神经退行性疾病 (NDD) 的区别.
  • 这项研究研究了涉及TDP-43的沉积物中的偏光相互作用,将其与AD中的粉样沉积物进行比较.

研究的目的:

  • 为了比较与TDP-43蛋白质病变 (ALS/FTLD) 相关的视网膜沉积的偏光相互作用与阿尔茨海默病 (AD) 的粉样沉积的相互作用.
  • 评估该技术作为一种廉价,无染料,对神经退行性疾病的差异诊断工具的潜力.
  • 通过促进差异诊断,使早期和更适当的治疗成为可能.

主要方法:

  • 使用偏光进行视网膜成像,对来自ALS,FTLD和AD患者的样本进行成像.
  • 假定是粉样β (在AD) 和TDP-43 (在ALS/FTLD) 的沉积物被成像.
  • 对于每个沉积物,计算出了九种不同的偏光相互作用,并将疾病组之间进行了比较.

主要成果:

  • 视网膜沉积与AD (粉样β) 和ALS/FTLD (TDP-43) 相一致,使用偏光可视化.
  • 在AD和TDP-43视网膜沉积物之间观察到多重偏光相互作用的显著差异.
  • 相互作用强度和沉积面积的一些重叠表明了组合诊断标记物的潜力.

结论:

  • 明显的偏光相互作用与视网膜中的不同蛋白质沉积 (粉样蛋白与TDP-43) 相相关,反映了大脑病理.
  • 这些相互作用的结合可能会导致神经退行性疾病的早期,非侵入性和成本有效的差异诊断.
  • 这种方法对诊断涉及粉样蛋白β,α-synuclein和TDP-43.3的疾病具有前景.